< Back

Thomas Wagner

Merck KGaA
Leader background:
Thomas is a biologist by training and was working hard to unravel the mysteries of the brain using his own brain and such obscure things as glass needles, fluorescent dyes and white powders called neurotransmitters. However, in order to avoid going mad himself, he quit university and started his medical writing career in 1999 with the CRO Kendle in Munich. In 2002 he changed to big pharma and worked for Lilly Deutschland GmbH, mainly writing on Phase III-IV projects, including observational studies. Still working in the area of madness he mostly tackled psychiatry, quality of life, and red tape in the position of Group Leader Scientific Communications Europe for Neurosciences at Eli Lilly & Co. To avoid getting entangled too much he then changed in 2009 to the other side of the fence now working as a service provider and consultant for Trilogy Writing & Consulting as Medical Writing Manager. Finally in 2015 Thomas moved to the headquarters of Merck KGaA in Germany and is responsible for all regulatory medical writing documents from Phase I to post-marketing studies in the “beyond oncology” area.
Effective Reporting of Scales, Questionnaires and VAS
    Level: Advanced Area: Professional Techniques
    Code: PTA10 Duration: 03:30:00
Medical Writing for Non-interventional and Database Studies
    Level: Advanced Area: Drug Development
    Code: DDA29 Duration: 03:30:00
Best-practices and guidance on the communication of RWE
    Level: Area: Symposium
    Code: Sym7.7 Duration: 00:40:00
PANEL DISCUSSION – Potential pitfalls of RWE for the medical writer and how to overcome them
    Level: Area:
    Code: Sym7.8 Duration: 00:45:00